Core 3: Communications, Administrations, Advocacy, and Project Management
核心 3:沟通、行政、宣传和项目管理
基本信息
- 批准号:10628613
- 负责人:
- 金额:$ 26.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-08 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AchievementAdvocacyAdvocateBreast Cancer TreatmentBudgetsClinicalClinical Drug DevelopmentCollaborationsCommunicationElementsEnsureFriendsGenerationsGoalsHuman ResourcesIndividualInfrastructureLeadershipMagnetic Resonance ImagingMeasurableMeasuresMethodologyModificationOffice of Administrative ManagementOutcomeParticipantPatient-Focused OutcomesPatientsProgram Research Project GrantsProtocols documentationRegimenRegulatory PathwayReportingResearch PersonnelRoleScienceSequential TreatmentSpecific qualifier valueStructureSubgroupTrainingTranslatingTranslational ResearchWorkdesignimaging biomarkerimprovedmalignant breast neoplasmmeetingsmolecular markernext generationnoveloperationpersonalized medicineprogramsresponse biomarkerrestrainttimelinetooltreatment responsetreatment strategytrial designwebinarworking group
项目摘要
The Program Project encompasses four integrated projects to develop and maintain the infrastructure for developing and
implementing improvements in the I-SPY2.2 trial that employs early escalation/de-escalation of treatment and identifies
treatment strategies to optimize patient outcomes within a regulatory evidence generation framework. The primary aims
of the Communications, Administration, Advocacy, and Project management (CAAP) Core are to ensure program
integration, collaboration, patient acceptance, and regulatory compliance by providing project management, leadership,
and administrative support to all Projects and Cores; as well as the integration of advocacy in all patient-facing aspects of
the Projects and Core in the Program Project.
Perhaps the most critical role of the CAAP core is to coordinate the activities and deliverables of the projects and cores
with the study sponsor QLHC, its clinical operations team and the I-SPY2 trial working group chairs. While program
project personnel, cores and projects are tasked with developing and refining the technical and methodological advances
required in the continuous improvement approach employed in I-SPY2.2, all operational aspects of the trial are the
responsibility of the study sponsor. The Program Project overall PIs and project PIs, facilitated by the CAAP core, work
to integrate the changes into the operations of the trial with sponsor representatives by defining the technical
requirements, specifications, and deliverables for the sponsor’s clinical operations team.
Among its other responsibilities, the CAAP Core ensures that our patient advocates are represented on all project teams,
cores teams and inter-project collaborations, so that they can bring their unique and important perspective to help meet the
patient-centric mandate of I-SPY2.2.
Specific Aim 1: Organize, integrate, and provide administrative management of all Projects and Core
Specific Aim 2: Provide project management oversight to track milestones and timelines of the individual Projects and
Cores.
Specific Aim 3: Facilitate collaborations and disseminate information
该计划项目包括四个综合项目,以开发和维护基础设施,
在I-SPY 2.2试验中实施改进,该试验采用早期升级/降级治疗,并确定
在监管证据生成框架内优化患者结局的治疗策略。主要目标
沟通、行政、宣传和项目管理(CAAP)核心的目的是确保项目
整合、协作、患者接受度和法规遵从性,提供项目管理、领导力,
为所有项目和核心提供行政支持;以及将宣传纳入所有面向患者的方面,
项目和核心项目。
CAAP核心最关键的作用可能是协调项目和核心的活动和交付成果
与研究申办者QLHC、其临床运营团队和I-SPY 2试验工作组主席一起。尽管程序
项目人员、核心和项目的任务是开发和完善技术和方法方面的进展
根据I-SPY 2.2中所采用的持续改进方法的要求,试验的所有操作方面都是
研究申办者的责任。在CAAP核心的推动下,
与申办者代表一起,通过定义技术
申办者临床运营团队的要求、质量标准和可交付成果。
在其其他职责中,CAAP核心确保我们的患者倡导者在所有项目团队中都有代表,
核心团队和项目间合作,以便他们能够带来独特而重要的观点,以帮助满足
以病人为中心的I-SPY 2.2.
具体目标1:组织、整合并提供所有项目和核心项目的行政管理
具体目标2:提供项目管理监督,以跟踪各个项目的里程碑和时间表,
丹
具体目标3:促进合作和传播信息
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAURA J ESSERMAN其他文献
LAURA J ESSERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAURA J ESSERMAN', 18)}}的其他基金
Enhancing the Diversity of Participants in the WISDOM Clinical Trial: Practical Challenges and Ethical Implications
增强 WISDOM 临床试验参与者的多样性:实际挑战和伦理影响
- 批准号:
10367828 - 财政年份:2020
- 资助金额:
$ 26.66万 - 项目类别:
Extending the Diversity, Reach, and Generalizability of the WISDOM Study
扩展 WISDOM 研究的多样性、范围和普遍性
- 批准号:
10368970 - 财政年份:2020
- 资助金额:
$ 26.66万 - 项目类别:
Extending the Diversity, Reach, and Generalizability of the WISDOM Study
扩展 WISDOM 研究的多样性、范围和普遍性
- 批准号:
10593908 - 财政年份:2020
- 资助金额:
$ 26.66万 - 项目类别:
Extending the Diversity, Reach, and Generalizability of the WISDOM Study
扩展 WISDOM 研究的多样性、范围和普遍性
- 批准号:
9888251 - 财政年份:2020
- 资助金额:
$ 26.66万 - 项目类别:
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
I-SPY2:改进 I-SPY 2 试验,纳入 MRI 引导的适应性序贯治疗,以优化乳腺癌结果
- 批准号:
9789198 - 财政年份:2017
- 资助金额:
$ 26.66万 - 项目类别:
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
I-SPY2:改进 I-SPY 2 试验,纳入 MRI 引导的适应性序贯治疗,以优化乳腺癌结果
- 批准号:
10013133 - 财政年份:2017
- 资助金额:
$ 26.66万 - 项目类别:
相似海外基金
Transfer Advocacy Groups: Transforming Culture to Support Community College Transfer Students of Color in Undergraduate Physics
转学倡导团体:转变文化以支持社区学院本科物理有色人种转学生
- 批准号:
2224295 - 财政年份:2023
- 资助金额:
$ 26.66万 - 项目类别:
Continuing Grant
Engaging adolescents for sexual and reproductive health and rights and family planning advocacy in Pakistan.
让巴基斯坦青少年参与性健康和生殖健康及权利以及计划生育宣传。
- 批准号:
490127 - 财政年份:2023
- 资助金额:
$ 26.66万 - 项目类别:
Operating Grants
Developing a network for mutual learning on the potential of creative arts for mental health advocacy and activism in Ghana and Indonesia
建立一个网络,以相互学习创意艺术在加纳和印度尼西亚促进心理健康倡导和行动的潜力
- 批准号:
AH/X009637/1 - 财政年份:2023
- 资助金额:
$ 26.66万 - 项目类别:
Research Grant
Protection without Advocacy: Japan's Failure to Support Persons with Mental Disabilities in the community
没有倡导的保护:日本未能支持社区中的精神残疾人
- 批准号:
23K01937 - 财政年份:2023
- 资助金额:
$ 26.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Developing a cultural adaptation framework for youth mental health education and advocacy initiatives at Jack.org
Jack.org 为青少年心理健康教育和宣传活动制定文化适应框架
- 批准号:
484618 - 财政年份:2023
- 资助金额:
$ 26.66万 - 项目类别:
Fellowship Programs
8th International RASopathies Symposium: Expanding Research and Care Practice through Global Collaboration and Advocacy
第八届国际 RASopathies 研讨会:通过全球合作和宣传扩大研究和护理实践
- 批准号:
10683644 - 财政年份:2023
- 资助金额:
$ 26.66万 - 项目类别:
Lupus and health information: Evidence-informed advocacy in action
狼疮和健康信息:循证宣传在行动
- 批准号:
485670 - 财政年份:2023
- 资助金额:
$ 26.66万 - 项目类别:
Miscellaneous Programs
Initiating Meaningful Partnerships for Advocacy and Collaborative Training: The IMPACT initiative
发起有意义的倡导和协作培训伙伴关系:IMPACT 倡议
- 批准号:
487847 - 财政年份:2023
- 资助金额:
$ 26.66万 - 项目类别:
Miscellaneous Programs
Creating advocacy and tech to make secondhand first choice.
创造宣传和技术,让二手货成为首选。
- 批准号:
10064859 - 财政年份:2023
- 资助金额:
$ 26.66万 - 项目类别:
Collaborative R&D
Advocacy Strategies supporting Social Determinants of Health: Paving the Path to Community Reintegration and Recovery
支持健康问题社会决定因素的倡导策略:为社区重新融入和恢复铺平道路
- 批准号:
480718 - 财政年份:2023
- 资助金额:
$ 26.66万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




